Skip to content
PICO Portalanswers from OpenAlex

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

PaperCitations, authors & open-access status

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is a paper indexed in PICO Portal from OpenAlex.

How many citations does The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells have?

PICO Portalcitation count

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has 80 citations in the OpenAlex counts PICO Portal stores.

When was The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells published?

PICO Portalyear

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has 2014 year in the PICO Portal index.

What is the open-access status of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

PICO Portaloa status

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has diamond oa status in the PICO Portal index.

What is the DOI of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

PICO Portaldoi

The DOI for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

What is the PMID of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

PICO Portalpmid

The PMID for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

What is the OpenAlex record for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

PICO Portalopenalex

The OpenAlex for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial